Nancy A. Johnson

Array ( [id] => 3862068 [patent_doc_number] => 05837241 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Method of treating heart failure using leukemia inhibitory factor antagonists optionally with endothelin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/693826 [patent_app_country] => US [patent_app_date] => 1996-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 14171 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837241.pdf [firstpage_image] =>[orig_patent_app_number] => 693826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4223756 [patent_doc_number] => 06011041 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Use of anhydrovinblastine' [patent_app_type] => 1 [patent_app_number] => 8/690195 [patent_app_country] => US [patent_app_date] => 1996-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7617 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/011/06011041.pdf [firstpage_image] =>[orig_patent_app_number] => 690195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768497 [patent_doc_number] => 05807556 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Methods of preventing degeneration of myoplasties' [patent_app_type] => 1 [patent_app_number] => 8/683228 [patent_app_country] => US [patent_app_date] => 1996-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4737 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807556.pdf [firstpage_image] =>[orig_patent_app_number] => 683228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994554 [patent_doc_number] => 05892010 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Genes from the 20Q13 amplicon and their uses' [patent_app_type] => 1 [patent_app_number] => 8/680395 [patent_app_country] => US [patent_app_date] => 1996-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 15331 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/892/05892010.pdf [firstpage_image] =>[orig_patent_app_number] => 680395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4011079 [patent_doc_number] => 05889159 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Monoclonal antibodies to tumor marker TC1 and methods for use of same' [patent_app_type] => 1 [patent_app_number] => 8/448388 [patent_app_country] => US [patent_app_date] => 1996-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 57 [patent_no_of_words] => 10738 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889159.pdf [firstpage_image] =>[orig_patent_app_number] => 448388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790745 [patent_doc_number] => 05726024 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'p53as protein and antibody therefor' [patent_app_type] => 1 [patent_app_number] => 8/644291 [patent_app_country] => US [patent_app_date] => 1996-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 8379 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726024.pdf [firstpage_image] =>[orig_patent_app_number] => 644291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3767606 [patent_doc_number] => 05849539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Thymidine kinase-lacking ouabain-resistant chicken hybridoma' [patent_app_type] => 1 [patent_app_number] => 8/631571 [patent_app_country] => US [patent_app_date] => 1996-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6118 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849539.pdf [firstpage_image] =>[orig_patent_app_number] => 631571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047578 [patent_doc_number] => 05869445 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Methods for eliciting or enhancing reactivity to HER-2/neu protein' [patent_app_type] => 1 [patent_app_number] => 8/625101 [patent_app_country] => US [patent_app_date] => 1996-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13660 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869445.pdf [firstpage_image] =>[orig_patent_app_number] => 625101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989049 [patent_doc_number] => 05891651 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Methods of recovering colorectal epithelial cells or fragments thereof from stool' [patent_app_type] => 1 [patent_app_number] => 8/625015 [patent_app_country] => US [patent_app_date] => 1996-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5366 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891651.pdf [firstpage_image] =>[orig_patent_app_number] => 625015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3975693 [patent_doc_number] => 05958409 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Method for treating multiple sclerosis' [patent_app_type] => 1 [patent_app_number] => 8/586917 [patent_app_country] => US [patent_app_date] => 1996-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 21 [patent_no_of_words] => 9663 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958409.pdf [firstpage_image] =>[orig_patent_app_number] => 586917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3964227 [patent_doc_number] => 05885830 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Anti-ribonucleotide reductase R2 subunit monoclonal antibody' [patent_app_type] => 1 [patent_app_number] => 8/597803 [patent_app_country] => US [patent_app_date] => 1996-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 8385 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885830.pdf [firstpage_image] =>[orig_patent_app_number] => 597803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3821444 [patent_doc_number] => 05783186 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Antibody-induced apoptosis' [patent_app_type] => 1 [patent_app_number] => 8/568072 [patent_app_country] => US [patent_app_date] => 1995-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 8650 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783186.pdf [firstpage_image] =>[orig_patent_app_number] => 568072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3935704 [patent_doc_number] => 05939539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'GA 20-oxidase gene sequences' [patent_app_type] => 1 [patent_app_number] => 8/553367 [patent_app_country] => US [patent_app_date] => 1995-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29285 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939539.pdf [firstpage_image] =>[orig_patent_app_number] => 553367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3763846 [patent_doc_number] => 05844093 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Anti-EGFR single-chain Fvs and anti-EGFR antibodies' [patent_app_type] => 1 [patent_app_number] => 8/553497 [patent_app_country] => US [patent_app_date] => 1995-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 13975 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/844/05844093.pdf [firstpage_image] =>[orig_patent_app_number] => 553497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994370 [patent_doc_number] => 05891996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use' [patent_app_type] => 1 [patent_app_number] => 8/560558 [patent_app_country] => US [patent_app_date] => 1995-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 8163 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891996.pdf [firstpage_image] =>[orig_patent_app_number] => 560558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4050375 [patent_doc_number] => 05869618 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Antibodies to ligand growth factors' [patent_app_type] => 1 [patent_app_number] => 8/550815 [patent_app_country] => US [patent_app_date] => 1995-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 43 [patent_no_of_words] => 33290 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869618.pdf [firstpage_image] =>[orig_patent_app_number] => 550815 [rel_patent_id] =>[rel_patent_doc_number] =>)